Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

PACIRA BIOSCIENCES, INC.

(PCRX)
  Report
Real-time Estimate Cboe BZX  -  12:49 2022-11-28 pm EST
49.36 USD   -0.66%
11/15Sector Update: Health Care Stocks Edge Higher Premarket Tuesday
MT
11/15Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October; Wedbush Maintains Forecast
MT
11/14Pacira BioSciences Reports Higher Exparel Preliminary Net Product Sales in October
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds
Sector news Other Pharmaceuticals
11/25Sun Pharmaceutical's Psoriatic Arthritis Drug Up for Strong Sales Once Available
MT
11/25Elon Musk says Twitter's verified service with colors to start next week
RE
11/24Researchers test mRNA technology for universal flu vaccine
RE
11/23European Commission Orders Treatment Courses Of Pfizer's COVID-19 Pill
MT
11/23Sector Update: Health Care Stocks Advancing Wednesday Afternoon
MT
11/23Sector Update: Health Care Stocks Still Advancing in Wednesday Trading
MT
11/23Sector Update: Health Care
MT
11/23Correction: Fed Minutes Eyed for Signs of Slower Fed Rate Hikes as ETFs, Stoc..
MT
11/23Fed Minutes Eyed for Signs of Slower Fed Rate Hikes as ETFs, Stock Futures Inch Higher ..
MT
11/23PFIZER INC : From Sell to Buy by Credit Suisse
MD
11/23Johnson & Johnson's Janssen Pharmaceutical Says Phase 3 Trial of Major Depressive Disor..
MT
11/23AbbVie Says European Commission Approves Skyrizi for Treatment of Crohn's Disease
MT
11/23AbbVie Announces European Commission Approval of SKYRIZI« (risankizumab) for the Treatm..
CI
11/22Merck & Co.'s Keytruda Combo Extends Survival in Late-stage Stomach Cancer Study
MT
11/22Australia's CSL prices hemophilia gene therapy at $3.5 million
RE
11/22Generic drugmakers Teva and Sandoz make major push to biosimilars
RE
11/22CDC Says Pfizer-BioNTech, Moderna New Boosters Better Than Older Formulation in COVID-1..
MT
11/22Factbox-Pharmacies, drug companies settle lawsuits over U.S. opioid crisis
RE
11/22Teva, AbbVie finalize $6.6 billion U.S. opioid settlements
RE
11/22Teva, Allergan Finalize Terms of Nationwide Opioid Settlement -- Update
DJ
11/22Teva Pharmaceutical Industries, Sandoz Plan to Boost Production of Biosimilars
MT
11/22Merck's Keytruda Meets Primary Endpoint in Phase 3 Trial of Keytruda in Gastric Cancer ..
MT
11/22Merck's Keytruda Hits Main Endpoint in Stomach Cancer Study
DJ
11/22Berenberg Bank Raises Eli Lilly and Co. PT to $375 From $345, Says Underlying Performan..
MT
11/22Arvinas, Inc. Announces Initial Results from Phase 2 Cohort Expansion Portion of Phase ..
CI
11/22Merck Announces Phase 3 Keynote-859 Trial Met Primary Endpoint of Overall Survival in P..
CI
11/22CORRECTED (OFFICIAL) -FOCUS-Generic drugmakers Teva and Sandoz make major push to biosi..
RE
11/22Shionogi's Covid-19 Drug Gets Panel Approval in Japan
DJ
11/22Buying in Public Sector Bank Stocks Aids Indian Equities Snap Losing Run; IndusInd Bank..
MT
11/22Glenmark Pharmaceuticals Reaches Settlement with Pfizer Over Kidney Cancer Drug
MT
11/21Glenmark Pharmaceuticals Reaches Settlement Agreement with Pfizer for Axitinib Tablets,..
CI
11/21Merck & Co. To Buy Bone Marrow Disease-focused Imago BioSciences For $1.4 Billion
MT
11/21Insider Sell: Johnson & Johnson
MT
11/21Sector Update: Health Care Stocks Advance Modestly
MT
11/21Trending : Merck to Acquire Imago BioSciences for $1.35 Billion
DJ
11/21Sector Update: Health Care Stocks Staying on Positive Ground
MT
11/21Top Midday Gainers
MT
11/21Merck Eyes Expanded Blood Disorder Drug Pipeline Via $1.35 Billion Buyout of Imago BioS..
MT
11/21Imago BioSciences Shares Take Flight on Takeover by Merck
DJ
11/21Wedbush Downgrades Imago BioSciences to Neutral From Outperform on Heels of Announced S..
MT
11/21Sector Update: Health Care Stocks Mixed Pre-Bell Monday
MT
11/21Rising Covid Cases in China Pressuring US Equities' Trading Sentiment
MT
11/21Exchange-Traded Funds Preview: ETFs, Stock Futures Mixed A..
MT
11/21AbbVie Says Epcoritamab Obtains FDA Priority Review for Treatment of Large B-Cell Lymph..
MT
11/21AbbVie, Genmab Get FDA Priority Review of Epcoritamab in Large B-Cell Lymphoma
DJ
11/21AbbVie Inc. Announces Acceptance of Biologics License Application for Epcoritamab by U...
CI
11/21Merck to Buy Imago for $36 A Share, More Than Double Friday's Close
DJ
11/21Merck to Acquire Imago BioSciences in $1.35 Billion Deal; Imago Shares Surge Pre-Bell
MT
11/21Aosaikang Pharma Wins Nod to Market Variant of Pfizer's Breast Cancer Drug
MT
11/18Pfizer's Updated Omicron Booster Shows Improved Immunity Against New Variants
MT
11/18Transcript : Pfizer Inc. Presents at 4th Annual Wolfe Research Healthcare Con..
CI
11/18Pfizer, BioNTech Says Bivalent COVID-19 Vaccine Shows 'Greater' Response
MT
11/18Credit Suisse Starts Eli Lilly at Outperform With $395 Price Target
MT
11/18Credit Suisse Starts Merck at Outperform With $120 PT, Notes High Near-Term Growth, Low..
MT
11/18Credit Suisse Starts AbbVie at Outperform With $170 Price Target
MT
11/18Credit Suisse Starts Johnson & Johnson at Neutral With $170 Price Target
MT
11/18Credit Suisse Starts Pfizer at Outperform With $55 Price Target
MT
11/18Pfizer, BioNTech Say Bivalent COVID-19 Booster Showed Improved Immune Response Against ..
MT
11/18Pfizer/BioNTech Omicron shot shows immune response against BQ.1.1 in older adults
RE
11/18Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demon..
CI
11/18Factbox-Twitter 2.0: Musk warns of bankruptcy, flip-flops on blue ch..
RE
11/18Factbox-Advertisers react to Twitter's new ownership
RE
11/18Analyst recommendations: AbbVie, Bristol-Myers, Dominion Energy,..
MS
11/18Big Pharma may have to reveal government deals in WHO's draft pandemic rules
RE
11/17CytomX Therapeutics Shares Rally on Regeneron Pact
DJ
11/17Morgan Stanley Slashes Price Target on Eli Lilly to $436 From $441, Affirms Overweight ..
MT
11/17Schroder UK Public invests USD1.2 million in A2 Biotherapeutics
AN
11/16Pfizer, BioNTech Begin Phase 1 Study Of New COVID-19 Shot With Longer Protection
MT
11/16Pfizer Inc. and BioNTech SE Advances Next-Generation COVID-19 Vaccine Strategy with Stu..
CI
11/16Pfizer's Paxlovid, Eli Lilly's Olumiant Backed by UK Drug Watchdog in Draft Guidance
MT
11/16AbbVie Gets Health Canada Approval for Ubrelvy Tablet to Treat Migraines
MT
11/16AbbVie Announces Health Canada's Approval of UBRELVY« for the Acute Treatment of Migrai..
CI
11/16XORTX Therapeutics Appoints Former Pfizer Executive Stacy Evans as Chief Business Offic..
MT
11/15UK Drug Pricing Agency Rejects Merck & Co.'s Molnupiravir, Four Other COVID-19 Treatmen..
MT
11/15Britain's NICE recommends against NHS use of 5 COVID treatments as not cost-effective
RE
11/15Transcript : AbbVie Inc. Presents at 4th Annual Wolfe Research Healthcare Con..
CI
11/15Novo Nordisk CEO Unfazed By Imminent Entry of Rival Obesity Drugs from Amgen, Lilly
MT
11/14Japan's Daiichi Sankyo says mRNA COVID vaccine successful in booster trial
RE
11/14Moderna New Omicron Boosters Show Stronger Response, Indicate Neutralizing Activity Aga..
MT
11/14Truist Securities Raises Eli Lilly and Company's Price Target to $421 From $400, Mainta..
MT
11/14Merck, AstraZeneca Prostate Cancer Treatment Receives European Medicines Agency Recomme..
MT
11/14Factbox-Twitter 2.0: Elon Musk warns of bankruptcy, flip-flops on bl..
RE
11/14Akouos Q3 Loss Narrows
MT
11/14Satsuma Pharma's migraine drug fails late-stage study, shares crash
RE
11/14Astrazeneca and Merck Announces Lynparza« in Combination with Abiraterone and Prednison..
CI
11/14Social Buzz: Wallstreetbets Stocks Mixed Premarket; Coinbase Global Poised t..
MT
11/14Hutchmed's Combo Therapy Shows Improvement In Gastric Cancer Trial In China
MT
11/14AstraZeneca's Three Cancer Therapies Backed for Expanded Approval in EU
MT
11/11Eli Lilly Down Over 6%, on Pace for Largest Percent Decrease Since March 2021 -- Data T..
DJ
11/11Johnson & Johnson On Track for Largest Percent Decrease Since June 2020 -- Data Talk
DJ
11/11Johnson & Johnson Announces New Post-Hoc Analysis of the Phase 3 Discover Program
CI
11/11Pfizer's India arm posts profit jump on lower costs, price hikes
RE
11/10Insider Sell: Merck & Co.
MT
11/10Insider Sell: Johnson & Johnson
MT
11/10Immutep Reports 'Compelling' Data from Mid-Stage Lung Cancer Trial; Shares Rise Midday
MT
11/10Pfizer-BioNTech Bivalent COVID-19 Booster Vaccine Receives Marketing Authorization Reco..
MT
11/10European Medicines Agency Panel Backs Pfizer-BioNTech Bivalent COVID-19 Vaccine Booster..
MT
11/10Pfizer and Biontech Receive Positive Chmp Opinion for Omicron Ba.4/Ba.5-Adapted Bivalen..
CI
11/10Haleon Upgrades 2022 Views After 3Q Revenue Rose on Pricing, Volumes
DJ
11/10AstraZeneca lifts 2022 earnings outlook as cancer drugs boost results
RE
Upcoming event on PACIRA BIOSCIENCES, INC.